Studies

Male Overactive Badder

Boston Scientific | MOAB | NCT06511141

Male Overactive Bladder

Calyxo | SCORE | NCT07155005

Renal Stones

High Risk Non-Muscle Invasive Bladder Cancer

CG Oncology | CORE-008 | NCT06567743

High Risk Non-Muscle Invasive Bladder Cancer

High Risk Non-Muscle Invasive Bladder Cancer

CG Oncology | CRETO-EAP | NCT06443944

High Risk Non-Muscle Invasive Bladder Cancer

Metastatic Castrate-Resistant Prostate Cancer

Dendreon | ProvONE | NCT06134232

Metastatic Castrate-Resistant Prostate Cancer

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ferring | ABLE-32 | NCT06510374

Intermediate Risk Non-Muscle Invasive Bladder Cancer

ImmunityBio | ResQ132EX | NCT06810141

High Risk Non-Muscle Invasive Bladder Cancer

Pfizer | MEVPRO-3 | NCT07028853

Metastatic Castrate-Sensitive Prostate Cancer

Localized Prostate Cancer

Procept BioRobotics | WATER IV | NCT06651632

Localized Prostate Cancer

Protara | ADVANCED-3 | NCT07480356

High Risk Non-Muscle Invasive Bladder Cancer